Streetbeat News

Regulatory

SLRX

Salarius Pharmaceuticals shares are trading lower after the company was notified by MD Anderson Cancer Center of a Grade 4 adverse event in the Seclidemstat clinical trial. The FDA has placed the trial on partial clinical hold, preventing new patient enrollment while allowing current patients to continue treatment.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 3:12 pm

SPY

President Biden's campaign aide has stated that Biden is not wavering on any of his policies, according to Bloomberg.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 2:51 pm

DIS

NFLX

Netflix is expected to report higher Q2 earnings, with analysts revising forecasts upwards. The company, along with Disney, is challenging a new Canadian regulation. Netflix shares fell 1.4% recently. Analysts have maintained positive ratings and increased price targets for Netflix.

Portfolio Pulse from Avi Kapoor

July 18, 2024 | 2:41 pm

BTI

R.J. Reynolds has received FDA marketing approval for 7 Vuse e-cigarettes, a significant regulatory milestone for the company.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 2:26 pm

SPY

Federal Reserve's Goolsbee stated that recent inflation data has been positive, but the fight against inflation is not over. He also noted that the labor market is cooling, leading to a better balance.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 2:07 pm

AMD

BYND

DPZ

LESL

NVDA

Bitcoin Spot ETFs continue to see inflows, while Trump's comments on Taiwan and Biden's trade plans trigger a selloff in semiconductor stocks. Leslie's, Beyond Meat, and Domino's are among the big stocks moving lower in pre-market trading. Nvidia and AMD are particularly affected by the semiconductor selloff.

Portfolio Pulse from Akanksha Bakshi

July 18, 2024 | 2:04 pm

VLCN

Volcon Inc. has regained compliance with Nasdaq's listing requirements, ensuring its continued presence on the exchange.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 1:34 pm

EWQ

FEZ

FXE

The European Central Bank (ECB) kept its key interest rates unchanged at its July meeting, aligning with market expectations. The ECB did not provide specific guidance on future policy, slightly chilling market expectations for a September rate cut. The euro held steady against the U.S. dollar, and European equity markets rose, with France's CAC 40 index being the top performer.

Portfolio Pulse from Piero Cingari

July 18, 2024 | 1:18 pm

NXGL

NEXGEL, Inc. (NASDAQ:NXGL) and Innovative Optics US have initiated an IRB study to measure the efficacy of NEXGEL's hydrogel in eliminating harmful particles during laser hair removal. The study is funded by Innovative Optics US and aligns with FDA guidelines. Several states are considering mandates for surgical plume protection.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 1:17 pm

HAIL

XPEV

XPeng Inc (NYSE:XPEV) shares are trading lower in the premarket session due to reports of potential U.S. chip sale restrictions on China. Despite this, XPeng's partnership with Volkswagen is progressing, with significant collaboration in EV technology. Volkswagen plans to invest $700 million in XPeng and co-develop two EV models. XPeng's G6 model also made its U.K. debut recently.

Portfolio Pulse from Nabaparna Bhattacharya

July 18, 2024 | 1:17 pm